Literature DB >> 15789144

Tension-free vaginal tape: a prospective subjective and objective outcome analysis.

Holly E Richter1, Andy M Norman, Kathryn L Burgio, Patricia S Goode, Kate Clark Wright, Jodie Benton, R Edward Varner.   

Abstract

The purpose of this prospective study was to describe the effects of the tension-free vaginal tape (TVT) procedure on subjective and objective outcomes. Eighty-seven women (aged 31-95 years) underwent a TVT procedure and were followed for up to 24 months using the Incontinence Impact Questionnaire (IIQ-7), Urogenital Distress Inventory (UDI-6), and a Patient Satisfaction Questionnaire. IIQ-7 scores improved from a mean 51.1 before surgery to 12.7 at 1 month (p<0.001) indicating reduced impact of incontinence on quality of life. UDI-6 scores declined from a mean 61.8 to 21.9 (p<0.001) indicating improvement in urinary symptoms. At 1 month, 91.2% of patients were satisfied. Improvements on all measures were maintained throughout follow-up. Urodynamic evaluation of 57 patients (mean: 15.0 months) showed that 91.2% had a negative stress test. Results indicate significant immediate and sustained improvement in incontinence impact and urinary symptoms, and a high rate of patient satisfaction and objective cure.

Entities:  

Mesh：

Year:  2004        PMID： 15789144     DOI： 10.1007/s00192-004-1238-5

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  18 in total

1.  The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology.

Authors:  P Abrams; J G Blaivas; S L Stanton; J T Andersen
Journal:  Scand J Urol Nephrol Suppl       Date:  1988

2.  Reliability assessment of the bladder diary for urinary incontinence in older women.

Authors:  J L Locher; P S Goode; D L Roth; R L Worrell; K L Burgio
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-01       Impact factor: 6.053

3.  Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence.

Authors:  C G Nilsson; N Kuuva; C Falconer; M Rezapour; U Ulmsten
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

4.  Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial.

Authors:  Kathryn L Burgio; Patricia S Goode; Julie L Locher; Mary G Umlauf; David L Roth; Holly E Richter; R Edward Varner; L Keith Lloyd
Journal:  JAMA       Date:  2002-11-13       Impact factor: 56.272

5.  Tension-free vaginal tape for primary genuine stress incontinence: a two-centre follow-up study.

Authors:  P A Moran; K L Ward; D Johnson; W E Smirni; P Hilton; J Bibby
Journal:  BJU Int       Date:  2000-07       Impact factor: 5.588

6.  A nationwide analysis of complications associated with the tension-free vaginal tape (TVT) procedure.

Authors:  Nina Kuuva; Carl Gustaf Nilsson
Journal:  Acta Obstet Gynecol Scand       Date:  2002-01       Impact factor: 3.636

7.  Burch colposuspension and tension-free vaginal tape in the management of stress urinary incontinence in women.

Authors:  A Liapis; P Bakas; G Creatsas
Journal:  Eur Urol       Date:  2002-04       Impact factor: 20.096

8.  Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence.

Authors:  Karen Ward; Paul Hilton
Journal:  BMJ       Date:  2002-07-13

9.  Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group.

Authors:  J S Uebersax; J F Wyman; S A Shumaker; D K McClish; J A Fantl
Journal:  Neurourol Urodyn       Date:  1995       Impact factor: 2.696

10.  Efficacy of tension-free vaginal tape with other pelvic reconstructive surgery.

Authors:  Linda M Partoll
Journal:  Am J Obstet Gynecol       Date:  2002-06       Impact factor: 8.661
View more
  6 in total

1.  Body mass index as a risk factor for cystotomy during suprapubic placement of mid-urethral slings.

Authors:  Gena C Dunivan; AnnaMarie Connolly; Mary L Jannelli; Ellen C Wells; Elizabeth J Geller
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-06-06

2.  A long-term study of the effects of the tension-free vaginal tape procedure for female stress urinary incontinence on voiding, storage, and patient satisfaction: a post-hoc analysis.

Authors:  Ji-Yeon Han; Cheryn Song; Junsoo Park; Hee Chang Jung; Kyu-Sung Lee; Myung-Soo Choo
Journal:  Korean J Urol       Date:  2010-01-21

3.  Condition-specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence.

Authors:  Larry T Sirls; Sharon Tennstedt; Emily Lukacz; Leslie Rickey; Stephen R Kraus; Alayne D Markland; Kimberly Kenton; Pam Moalli; Yvonne Hsu; Liyuan Huang; Anne M Stoddard
Journal:  Female Pelvic Med Reconstr Surg       Date:  2012 Sep-Oct       Impact factor: 2.091

4.  A multi-centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension-free, suburethral sling treatment of urodynamic stress incontinence: the TORP study.

Authors:  Christopher Barry; Yik Nyok Lim; Reinhold Muller; Sarah Hitchins; Audrey Corstiaans; Andrew Foote; Hugh Greenland; Malcolm Frazer; Ajay Rane
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-07-19

5.  Outpatient mid-urethral tissue fixation system sling for urodynamic stress urinary incontinence: 3-year surgical and quality of life results.

Authors:  Ryoko Nakamura; Masahiro Yao; Yoshiko Maeda; Akiko Fujisaki; Yuki Sekiguchi
Journal:  Int Urogynecol J       Date:  2017-05-12       Impact factor: 2.894

Review 6.  Distress and quality of life characteristics associated with seeking surgical treatment for stress urinary incontinence.

Authors:  Karen M Gil; Amber M Somerville; Sara Cichowski; Jennifer L Savitski
Journal:  Health Qual Life Outcomes       Date:  2009-02-05       Impact factor: 3.186
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.